IONQ (IONQ) shareholder files Form 144 to sell 25,000 common shares

Rhea-AI Filing Summary

A shareholder of IONQ filed a Form 144 notice covering a planned sale of 25,000 common shares through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of $1,216,250. The filing notes that there were 354,279,591 common shares outstanding as of the time referenced. The shares to be sold stem from 25,000 restricted stock units acquired on 09/10/2024 from the issuer.

The seller, identified in the past‑sales section as Rima Alameddine, reports additional common share sales in the prior three months under a Rule 10b5‑1 trading plan, including 25,000 shares on 11/28/2025 for $1,241,500.00, 100,000 shares on 11/20/2025 for $4,689,060.00, and 19,976 shares on 09/11/2025 for $886,966.36. The new 25,000‑share sale is expected around 12/04/2025.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	25000	1216250.00	354279591	12/04/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/10/2024	Restricted Stock Units	Issuer			25000	09/10/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for RIMA ALAMEDDINE 4505 Campus Drive College Park MD 20740	Common	11/28/2025	25000	1241500.00
10b5-1 Sales for RIMA ALAMEDDINE 4505 Campus Drive College Park MD 20740	Common	11/20/2025	100000	4689060.00
RIMA ALAMEDDINE 4505 Campus Drive College Park MD 20740	Common	09/11/2025	19976	886966.36

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the latest Form 144 filing for IONQ disclose?

The Form 144 filing for IONQ discloses a planned sale of 25,000 common shares through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of $1,216,250. These shares come from restricted stock units acquired on 09/10/2024.

How many IONQ shares are planned to be sold and when?

The notice covers a planned sale of 25,000 IONQ common shares, with an approximate sale date of 12/04/2025 listed in the filing.

What recent IONQ share sales does the Form 144 report for the last 3 months?

The filing reports recent sales for Rima Alameddine: 25,000 common shares on 11/28/2025 for $1,241,500.00, 100,000 shares on 11/20/2025 for $4,689,060.00, and 19,976 shares on 09/11/2025 for $886,966.36.

How many IONQ shares are outstanding according to this Form 144?

The Form 144 states that there are 354,279,591 common shares outstanding for the issuer at the time referenced.

What is the source of the IONQ shares being sold under this Form 144?

The 25,000 common shares to be sold were acquired as restricted stock units on 09/10/2024 from the issuer, as shown in the acquisition table.

Is a Rule 10b5-1 trading plan referenced in the IONQ Form 144?

Yes. The past sales section refers to 10b5-1 sales for Rima Alameddine, and the representation section notes that a written trading plan or trading instructions may be used to satisfy Rule 10b5-1.